Perfil
Karen B.
Chapman is the founder of Origen Therapeutics, Inc. She worked as the Vice President-Research at OncoCyte Corp.
from 2011 to 2017.
Chapman holds a graduate degree from Cornell University and a doctorate degree from The Johns Hopkins University School of Medicine, which she received in 1991.
Antiguos cargos conocidos de Karen B. Chapman.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOCYTE CORPORATION | Director Técnico/Científico/I+D | 22/03/2017 |
Origen Therapeutics, Inc.
 Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Fundador | - |
Formación de Karen B. Chapman.
| Cornell University | Graduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Karen B. Chapman
